Abstract
One of the most significant somatic diseases that aggravate the course of chronic dermatoses is diabetes mellitus (DM). The course of papulo-squamous dermatoses, allergic skin diseases, bacterial and fungal infections in patients with DM is characterized by a continuously recurrent course, special resistance to treatment. Dermatoses-markers of DM – diabetic dermatopathies deserve special attention. Ulcerative necrotic process in the skin, total mycotic lesion of the nail plates, persistent dermatomycosis in patients with DM is often a predicted outcome of persistent pain-free ischemia of the lower extremities. A good level of glycemia in patients with DM and metabolic syndrome is the key to preventing specific dangerous consequences – cardiovascular autonomic mononeuropathy, nephropathy, retinopathy, peripheral polyneuropathy and dermatopathy. Non-drug therapy of patients with DM should include a whole range of measures to comply with diet, lifestyle changes and mandatory self-monitoring of glycemia levels. Such measures will significantly reduce the risk of severe complications of prolonged hyperglycemia and will reduce the drug load, which is an inevitable measure for patients with diabetes. An essential condition for the successful selection of therapy for patients with diabetes is active self-monitoring of blood glucose indicators. One of the leaders of modern blood glucose meters is the Сontour Plus One device, which meets current international standards.
Keywords: diabetic dermatopathy, diabetes mellitus, ulcerative pyoderma, macroangiopathy, glucometer.
Keywords: diabetic dermatopathy, diabetes mellitus, ulcerative pyoderma, macroangiopathy, glucometer.
For citation:Mashina M.V. MFeatures of the course of bacterial infection of the skin in patients with diabetes mellitus. Modern methods of glycemic control. Clinical observation. Clinical review for general practice. 2024; 5 (11): 118–124 (In Russ.). DOI: 10.47407/kr2024.5.11.00525
All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.
